Man

Francesco Mattia Mancuso

Bioinformatician

Vall d'Hebron Insitute of Oncology (VHIO)

Bacelona, España

Líneas de Investigación


Translational research to both accelerate and advance personalized and targeted therapies against cancer.

Educación

  •  Bioinformatics, University of Milano - Bicocca . Italia, 2006
  •  Molecular biotechnoogy, University of Milano - Bicocca . Italia, 2003

Experiencia Profesional

  •   Bioinformatician Full Time

    Vall d'Hebron Insitute of Oncology (VHIO)

    Barcelona, España

    2014 - A la fecha

  •   Bioinformatician Full Time

    Centre de Regulació Genomica (CRG)

    Barcelona, España

    2010 - 2014

  •   Bioinformatician Full Time

    I.E.O. (European Institute of Oncology)

    Milano, Italia

    2008 - 2010

  •   Bioinformatician Full Time

    Cogentech

    Milano, Italia

    2008 - 2010

  •   Bioinformatic technician Full Time

    PRIMM srl

    Milano, Italia

    2006 - 2007

  •   Bioinformatics Master student Full Time

    IFOM

    Milano, Italia

    2004 - 2005


 

Article (29)

Clinical value of next generation sequencing of plasma cell-free DNA in gastrointestinal stromal tumors
Epigenetic EGFR Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine Carcinomas
Identification of Expression Profiles Defining Distinct Prognostic Subsets of Radioactive-Iodine Refractory Differentiated Thyroid Cancer from the DECISION Trial
Impact of circulating tumor DNA mutant allele fraction on prognosis in RAS-mutant metastatic colorectal cancer
Activity of HSP90 Inhibiton in a Metastatic Lung Cancer Patient With a Germline BRCA1 Mutation
Early evolutionary divergence between papillary and anaplastic thyroid cancers
Genetic Profiles of Squamous Cell Carcinomas Associated with Recessive Dystrophic Epidermolysis Bullosa Unveil NOTCH and TP53 Mutations and an Increased MYC Expression
Multigene panel testing beyond BRCA1/2 in breast/ovarian cancer Spanish families and clinical actionability of findings
RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer
Proteotoxicity in cardiac amyloidosis: amyloidogenic light chains affect the levels of intracellular proteins in human heart cells
Rescuing discarded spectra: Full comprehensive analysis of a minimal proteome
Signatures of Evolutionary Adaptation in Quantitative Trait Loci Influencing Trace Element Homeostasis in Liver
miR-17-92 fine-tunes MYC expression and function to ensure optimal B cell lymphoma growth
Network-based proteomic approaches reveal the neurodegenerative, neuroprotective and pain-related mechanisms involved after retrograde axonal damage
The propagation of perturbations in rewired bacterial gene networks
The seipin complex Fld1/Ldb16 stabilizes ER-lipid droplet contact sites
Bioinformatic Approaches to Increase Proteome Coverage
Lifelong Exercise Training Modulates Cardiac Mitochondrial Phosphoproteome in Rats
Profiling the Secretome and Extracellular Proteome of the Potato Late Blight Pathogen Phytophthora infestans
Integrative quantitation enables a comprehensive proteome comparison of two Mycoplasma pneumoniae genetic perturbations
Data extraction from proteomics raw data: An evaluation of nine tandem MS tools using a large Orbitrap data set
Widespread generation of alternative UTRs contributes to sex-specific RNA binding by UNR
Substantial Histone Reduction Modulates Genomewide Nucleosomal Occupancy and Global Transcriptional Output
Identification and Analysis of Co-Occurrence Networks with NetCutter
Graph-based identification of cancer signaling pathways from published gene expression signatures using PubLiME
Lap2 alpha expression is controlled by E2F and deregulated in various human tumors
Mining published lists of cancer related microarray experiments: Identification of a gene expression signature having a critical role in cell-cycle control
Evolving Landscape of Molecular Prescreening Strategies for Oncology Early Clinical Trials
HumMeth27QCReport: an R package for quality control and primary analysis of Illumina Infinium methylation data
29
Francesco Mancuso

Bioinformatician

Cancer Genomics

Vall d'Hebron Insitute of Oncology (VHIO)

Bacelona, España